Table 3.
Distribution of Candida phenotype, virulence factors and antifungal sensitivity between Control, Homogenous and Non- Homogenous Oral leukoplakia.
| Controls (N = 30) | Homogenous Leukoplakia (N = 30) | Non- Homogenous Leukoplakia (N = 31) | |
|---|---|---|---|
| KOH stain | 0 | 3 | 2 |
| Culture | |||
| Candida albicans | 4 | 6 | 15 |
| Candida tropicalis | 0 | 1 | 0 |
| Candida parapsilosis | 0 | 0 | 1 |
| SAP activity | |||
| Negative | 0 | 1 | 2 |
| Weak | 3 | 1 | 0 |
| Poor | 1 | 0 | 1 |
| Moderate | 0 | 1 | 5 |
| Strong | 0 | 4 | 8 |
| PL activity | |||
| Negative | 1 | 5 | 8 |
| Weak | 2 | 1 | 0 |
| Poor | 1 | 0 | 1 |
| Moderate | 0 | 0 | 7 |
| Strong | 0 | 1 | 0 |
| Biofilm formation | |||
| Negative | 1 | 2 | 2 |
| Positive | 3 | 5 | 14 |
| Antifungal sensitivity (Fluconazole) | |||
| Sensitive | 4 | 6 | 15 |
| Resistant | 0 | 1 (Candida tropicalis) | 1 (Candida parapsilosis) |